Exploring links between vitamin D deficiency and COVID-19 M Mohan, JJ Cherian, A Sharma PLoS pathogens 16 (9), e1008874, 2020 | 219 | 2020 |
Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in mice RK Verma, WA Germishuizen, MP Motheo, AK Agrawal, AK Singh, ... Antimicrobial agents and chemotherapy 57 (2), 1050-1052, 2013 | 81 | 2013 |
Inhalable Microparticles Containing Nitric Oxide Donors: Saying NO to Intracellular Mycobacterium tuberculosis RK Verma, AK Singh, M Mohan, AK Agrawal, PRP Verma, A Gupta, ... Molecular pharmaceutics 9 (11), 3183-3189, 2012 | 44 | 2012 |
Inhalable microparticles containing isoniazid and rifabutin target macrophages and ‘stimulate the phagocyte’to achieve high efficacy AB Yadav, R Sharma, P Muttil, AK Singh, RK Verma, M Mohan, SK Patel, ... CSIR, 2009 | 39 | 2009 |
Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis RK Verma, AK Agrawal, AK Singh, M Mohan, A Gupta, P Gupta, UD Gupta, ... Tuberculosis 93 (4), 412-417, 2013 | 36 | 2013 |
Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis AB Yadav, P Muttil, AK Singh, RK Verma, M Mohan, AK Agrawal, ... Tuberculosis 90 (3), 188-196, 2010 | 35 | 2010 |
Inhaled therapies for tuberculosis and the relevance of activation of lung macrophages by particulate drug-delivery systems RK Verma, AK Singh, M Mohan, AK Agrawal, A Misra Therapeutic Delivery 2 (6), 753-768, 2011 | 25 | 2011 |
The devil’s advocacy: When and why inhaled therapies for tuberculosis may not work AB Yadav, AK Singh, RK Verma, M Mohan, AK Agrawal, A Misra Tuberculosis 91 (1), 65-66, 2011 | 21 | 2011 |
Particulate pulmonary delivery systems containing anti-tuberculosis agents A Gupta, SM Pandya, I Mohammad, AK Agrawal, M Mohan, A Misra Critical Reviews™ in Therapeutic Drug Carrier Systems 30 (4), 2013 | 19 | 2013 |
Challenges with mosquito-borne viral diseases: Outbreak of the monsters R Gautam, S Mishra, A Milhotra, R Nagpal, M Mohan, A Singhal, P Kumari Current Topics in Medicinal Chemistry 17 (19), 2199-2214, 2017 | 18 | 2017 |
Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month AK Singh, RK Verma, JK Mukker, AB Yadav, P Muttil, R Sharma, M Mohan, ... Tuberculosis 128, 102081, 2021 | 16 | 2021 |
Age-specific malaria vulnerability and transmission reservoir among children R Ranjha, K Singh, RK Baharia, M Mohan, AR Anvikar, PK Bharti Global Pediatrics 6, 100085, 2023 | 13 | 2023 |
Potent anti‐mycobacterial and immunomodulatory activity of some bioactive molecules of Indian ethnomedicinal plants that have the potential to enter in TB management A Sarangi, BS Das, G Patnaik, S Sarkar, M Debnath, M Mohan, ... Journal of Applied Microbiology 131 (4), 1578-1599, 2021 | 11 | 2021 |
Dendrimer-based drug delivery systems for tuberculosis treatment R Shukla, A Sethi, M Handa, M Mohan, PK Tripathi, P Kesharwani Nanotechnology based approaches for tuberculosis treatment, 163-174, 2020 | 10 | 2020 |
Host-directed therapy: a new arsenal to come M Mohan, D Bhattacharya Combinatorial Chemistry & High Throughput Screening 24 (1), 59-70, 2021 | 9 | 2021 |
Effects of host genetic polymorphisms on the efficacy of the radical cure malaria drug primaquine M Nain, M Mohan, A Sharma The American Journal of Tropical Medicine and Hygiene 106 (3), 764, 2022 | 5 | 2022 |
Profiles of host immune impairment in Plasmodium and SARS-CoV-2 infections R Chaturvedi, M Mohan, S Kumar, A Chandele, A Sharma Heliyon 8 (12), 2022 | 3 | 2022 |
Association of the C allele of rs479200 in the EGLN1 gene with COVID-19 severity in Indian population: a novel finding R Harit, S De, PK Singh, D Kashyap, M Kumar, D Sahu, CP Yadav, ... Human genomics 18 (1), 7, 2024 | 2 | 2024 |
Time to implement tailored interventions in Chhattisgarh, east-central India to reach malaria elimination R Ranjha, CP Yadav, M Mohan, K Singh, J Kumar, PK Bharti, AR Anvikar Journal of Vector Borne Diseases 61 (2), 151-157, 2024 | | 2024 |
Single-Nucleotide Polymorphisms in Glucose-6-Phosphate Dehydrogenase and their Relevance for the Deployment of Primaquine as a Radical Cure for Malaria M Nain, J Gill, M Mohan, A Sharma The American Journal of Tropical Medicine and Hygiene 108 (3), 470, 2023 | | 2023 |